Chronic neuropeptide S treatment improves sleep architecture and reduces Aβ-related pathology in APP/PS1 mice.

Zhao Y, Liu M, Zhou Y, Cui M, Cai N, Wang H, Liu G, Sun H, Kong X, Zhao P

Open source

DOI
10.3389/fneur.2026.1825666
Published
2026
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1825666,
  title = {Chronic neuropeptide S treatment improves sleep architecture and reduces Aβ-related pathology in APP/PS1 mice.},
  author = {Zhao Y and Liu M and Zhou Y and Cui M and Cai N and Wang H and Liu G and Sun H and Kong X and Zhao P},
  year = {2026},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2026.1825666},
  url = {https://doi.org/10.3389/fneur.2026.1825666}
}

RIS

TY  - JOUR
TI  - Chronic neuropeptide S treatment improves sleep architecture and reduces Aβ-related pathology in APP/PS1 mice.
AU  - Zhao Y
AU  - Liu M
AU  - Zhou Y
AU  - Cui M
AU  - Cai N
AU  - Wang H
AU  - Liu G
AU  - Sun H
AU  - Kong X
AU  - Zhao P
PY  - 2026
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1825666
UR  - https://doi.org/10.3389/fneur.2026.1825666
ER  - 

APA

Y, Z., M, L., Y, Z., M, C., N, C., H, W., G, L., H, S., X, K., & P, Z. (2026). Chronic neuropeptide S treatment improves sleep architecture and reduces Aβ-related pathology in APP/PS1 mice.. Frontiers in neurology. https://doi.org/10.3389/fneur.2026.1825666

Source records